Ropinirole suppresses LPS-induced periodontal inflammation by inhibiting the NAT10 in an ac4C-dependent manner

Haiqing Liao,Huabing Ma,Hongying Meng,Na Kang,Lufei Wang
DOI: https://doi.org/10.1186/s12903-024-04250-5
2024-05-01
BMC Oral Health
Abstract:Periodontitis is a chronic osteolytic inflammatory disease, where anti-inflammatory intervention is critical for restricting periodontal damage and regenerating alveolar bone. Ropinirole, a dopamine D2 receptor agonist, has previously shown therapeutic potential for periodontitis but the underlying mechanism is still unclear.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?